Loading...
Market
Will the drug company supply up to 2 million mpox vaccine doses by the end of 2024?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcements from the drug company or verified reports from the Africa CDC
Story
Drug Company to Produce Millions of Mpox Vaccines by Next Year
Aug 19, 2024, 09:00 AM
A drug company has announced plans to significantly increase production of millions of mpox vaccines by next year. The company, which is among the few firms with an mpox vaccine, has informed the Africa CDC that it can manufacture 10 million doses by the end of 2025. Additionally, it could supply up to 2 million doses this year. This announcement comes as the WHO has urged manufacturers to ramp up vaccine production in response to a potential mpox scare.
View original story
Similar markets
Moderna • 25%
Pfizer • 25%
AstraZeneca • 25%
Other • 25%
Company A • 25%
Company B • 25%
Company C • 25%
Other • 25%
Yes • 50%
No • 50%
Democratic Republic of the Congo • 25%
South Africa • 25%
Kenya • 25%
Uganda • 25%
Less than 1 million • 25%
1 to 3 million • 25%
3 to 5 million • 25%
More than 5 million • 25%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
Less than 500,000 • 25%
500,000 to 1 million • 25%
1 million to 2 million • 25%
More than 2 million • 25%
Yes • 50%
No • 50%
Less than 200,000 • 25%
200,000 to 300,000 • 25%
300,001 to 400,000 • 25%
More than 400,000 • 25%